Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pomalidomide: a new IMiD with remarkable activity in both multiple myeloma and myelofibrosis.

× No keyword cloud information.

5 in total

1. Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships.

Authors: George M Burslem; Philipp Ottis; Saul Jaime-Figueroa; Alicia Morgan; Philipp M Cromm; Momar Toure; Craig M Crews
Journal: ChemMedChem Date: 2018-07-04 Impact factor: 3.466

2. A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses.

Authors: Shandiz Shahbazi; Cody J Peer; Mark N Polizzotto; Thomas S Uldrick; Jeffrey Roth; Kathleen M Wyvill; Karen Aleman; Jerome B Zeldis; Robert Yarchoan; William D Figg
Journal: J Pharm Biomed Anal Date: 2014-01-09 Impact factor: 3.935

3. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.

Authors: Waqas Rehman; Lisa M Arfons; Hillard M Lazarus
Journal: Ther Adv Hematol Date: 2011-10

Review 4. Targeting ubiquitination for cancer therapies.

Authors: John Kenneth Morrow; Hui-Kuan Lin; Shao-Cong Sun; Shuxing Zhang
Journal: Future Med Chem Date: 2015-12-02 Impact factor: 3.808

Review 5. Profile of pomalidomide and its potential in the treatment of myelofibrosis.

Authors: Krisstina L Gowin; Ruben A Mesa
Journal: Ther Clin Risk Manag Date: 2015-04-02 Impact factor: 2.423

5 in total